{"doi":"10.1016/j.gore.2022.100993","title":"Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report","abstract":null,"journal":"Gynecologic Oncology Reports","year":2022,"id":614056,"datarank":0.31191623125197543,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"self_citation_contribution":0.31191623125197543,"citation_network_contribution":0.0,"self_endowment_contribution":0.31191623125197543,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":7,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1582232,"name":"Ryusuke Murakami","orcid":null,"position":1,"is_corresponding":false},{"id":1582233,"name":"Megumi Aki","orcid":null,"position":2,"is_corresponding":false},{"id":1582235,"name":"Yusuke Kawaguchi","orcid":null,"position":3,"is_corresponding":false},{"id":1582236,"name":"Yumi Takao","orcid":null,"position":4,"is_corresponding":false},{"id":1285394,"name":"Hirofumi Nonogaki","orcid":null,"position":5,"is_corresponding":false},{"id":1582238,"name":"Tomoyuki Goto","orcid":null,"position":6,"is_corresponding":false},{"id":1582240,"name":"Chikako Yamauchi","orcid":null,"position":7,"is_corresponding":false},{"id":1582231,"name":"Saki Sawayama","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report","abstract":"• We reported the use of pazopanib in the treatment of recurrent uterine carcinosarcoma with FGFR1 amplification. • The expert tumor board recommended pazopanib for off-label use based on genetic mutations found in cancer gene panels. • Pazopanib, a multi-tyrosine kinase inhibitor, was effective against recurrent uterine sarcoma with FGFR1 amplification. • Pazopanib maintained the patient’s quality of life for a certain period.","is_dataset_classified":null,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35586703","pmcid":null,"openalex_id":"https://openalex.org/W4225263728","authors":[],"funders":[],"total_grants":0,"fwci":0.4701,"citation_percentile":0.56609789,"influential_citations":0,"citation_trend":[{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":1},{"year":2025,"count":3},{"year":2026,"count":1}],"oa_status":"gold","license":"cc-by-nc-nd","oa_locations":[{"url":"https://doi.org/10.1016/j.gore.2022.100993","host_type":"journal"},{"url":"https://doi.org/10.1016/j.gore.2022.100993","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S235257892200073X?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S235257892200073X?httpAccept=text/plain","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35586703","host_type":"repository"},{"url":"https://doaj.org/article/caa9b0c2e9514a969b19a5fe6ebe1081","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9108727","host_type":"repository"}],"fields_of_study":["Fibroblast Growth Factor Research","Sarcoma Diagnosis and Treatment","Uterine Myomas and Treatments"],"mesh_terms":[],"keywords":["Pazopanib","Medicine","Carcinosarcoma","Tyrosine-kinase inhibitor","Fibroblast growth factor receptor 1","Sarcoma","Tyrosine kinase","Oncology","Cancer research","Internal medicine","Uterine sarcoma","Cancer","Fibroblast growth factor","Pathology","Carcinoma","Sunitinib","Receptor","FGFR, Fibroblast Growth Factor Receptor","UCS, uterine carcinosarcoma"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T10:27:32.822273Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}